• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SYNTHES GMBH TRAUMACEM V+ BONE CEMENT INJECTABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SYNTHES GMBH TRAUMACEM V+ BONE CEMENT INJECTABLE Back to Search Results
Catalog Number 07.702.040S
Device Problem Migration or Expulsion of Device (1395)
Patient Problem Insufficient Information (4580)
Event Date 11/06/2023
Event Type  malfunction  
Manufacturer Narrative
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If the information is unknown, not available or does not apply, the section/field of the form is left blank.H10 additional narrative: d9: complainant part is not expected to be returned for manufacturer review/investigation.H4, h6 product code: : 07.702.040s, lot number : 3072629, release to warehouse date : 14.June.2009, expiration date : na, supplier: na, manufacturing site: werk mezzovico.A manufacturing record evaluation was performed for the finished article lot and no non-conformances were identified.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event Description
Device report from synthes reports an event in japan as follows: it was reported that on (b)(6) 2023, the patient underwent the orif with the cement and the tfna for the femoral trochanteric fracture.After injection of the cement in question, the cement did not go deep enough and spread like an arrowhead.The cement may have leaked from the fracture area.It could not be confirmed by c arm, so that the surgeon will confirm with ct.The surgery was completed successfully without any surgical delay.Patient status/ outcome: stable no further information is available.This report is for one (1) traumacem v+ bone cement injectable this is report 1 of 1 for complaint (b)(6).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRAUMACEM V+ BONE CEMENT INJECTABLE
Type of Device
BONE CEMENT
Manufacturer (Section D)
SYNTHES GMBH
eimattstrasse 3
oberdorf 4436
SZ  4436
Manufacturer (Section G)
WERK MEZZOVICO
via cavazz 5
mezzovico 6805
SZ   6805
Manufacturer Contact
kate karberg
1302 wright lane east
west chester, PA 19380
3035526892
MDR Report Key18221687
MDR Text Key329775090
Report Number8030965-2023-14933
Device Sequence Number1
Product Code LOD
UDI-Device Identifier07611819453425
UDI-Public(01)07611819453425
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K170802
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/28/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number07.702.040S
Device Lot Number3072629
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/06/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/14/2009
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
UNK - NAILS: TFNA
-
-